Keyword: Centers for Disease Control and Prevention
With HIV rates in the U.S. holding steady, health officials are looking to drugmakers to help drive down infections. Now, Gilead is ready to chip in.
Here is some other vaccine news of note for the week.
Merck's 15-strain pneumococcal vaccine got an FDA breakthrough tag for children, months after Pfizer's 20-valent shot won one in adults.
After a horrible flu season last year, more people have gotten vaccinations so far this year, according to the CDC.
Experts urged the U.S. to allow CDC staff to return to the field, though WHO's director-general insists financial and other support should suffice.
GlaxoSmithKline is working to boost its supply of shingles vaccine Shingrix, but in the meantime, a shortage will last until next year.
The government is riled up about drug prices and promising to drive them down, but a CMS report shows retail drug spending grew just 0.4% last year.
A vaccine expert said the anti-vaccine movement is causing its first deaths and subjecting women to cervical cancer for "phony" reasons.
For the third year in a row, the percentage of U.S. kindergarteners with a vaccine exemption has grown, this time to 2.2%.
Having missed two flu seasons, AZ has swapped out FluMist's H1N1 component, which was linked to low efficacy that led to previous CDC rejections.